Bal Pharma Limited — Reply to Clarification- Financial results

Bal Pharma Limited has submitted a clarification to the stock exchanges regarding its financial results for the quarter ended March 31, 2026. The company was asked to provide details under Regulation 33 of SEBI's Listing Obligations and Disclosure Requirements. This regulation mandates listed entities to disclose specific financial information to ensure transparency for investors.

This clarification is a routine procedural step. It allows the company to address any queries the exchanges might have about its reported performance or financial position. For investors, this development signals that the company is in compliance with market regulations and is maintaining open communication with the exchange authorities.

Investors should look closely at the attached response to understand the specific points of clarification. This will provide clarity on the company's current financial standing and help in assessing its performance against market expectations.